Popular on TelAve
- PRP Aviation Earns Prestigious "Platinum Cirrus Training Center" Designation
- CCHR Cites Newly Released Mind Control Records to Oppose Psychedelics
- NaturismRE Introduces Global Accreditation Standards to Redefine Nudist and Naturist Venues
- Keells Leverages Cyntexa and Salesforce to Redefine Customer Loyalty with Digital Innovation
- K9 Technology President Files a Lawsuit Against Google LLC
- Alyrica Networks Approved as Oregon Lifeline Provider, Offering Affordable High-Speed Internet to Low-Income Households
- Enhancing Campus Safety for Women: The Blue Luna's New Initiative
- Greg Welch Joins Calovia as Managing and Founding Partner
- Transform Warehouse Operations: Redefining Logistics with Customized Solutions
- Windsor Brokers Launches 2% Interest on all Trading Accounts
Similar on TelAve
- Kelvin Emtech and Colm Engineering Unveil Strategic Joint Venture, to Boost Data Center and Building M&E Capabilities
- The Power Of Online Reviews & Why They Matter
- The One Experience™, Inc. Announces Presenting Sponsors and Partners for Flagship Event
- $27 Million Funding; Coverage on Sanjay Gupta/CNN for Treatment of Suicidal Depression; Nasdaq Tier Uplisting: NRx Pharmaceuticals: Stock Symbol: NRXP
- Performentor, LLC Announces 2025 Unleash People Energy® Award Winners
- Turbocharge Small- and Medium-Size Business Financing with Faster Funding's Innovative Business Credit Building and Financing Suite
- Inframark's Oklahoma City Team Wins OWEA Awards, Exemplary Employer Accolade
- Hitachi Construction Machinery estabelece sede regional na América Latina no Chile
- Hitachi Construction Machinery establece su sede regional para América Latina en Chile
- Hitachi Construction Machinery Establishing Latin American Regional Headquarters in Chile
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TelAve News/10821110
CAMBRIDGE, Mass. ~ On February 29, 2024, Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a leading company in precision genetic medicine for rare diseases, announced the granting of equity awards to five individuals who were recently hired by the company. These awards were previously approved by the Compensation Committee of Sarepta's Board of Directors under the 2014 Employment Commencement Incentive Plan and were given as a material inducement to employment.
According to Nasdaq Listing Rule 5635(c)(4), the equity awards included options to purchase a total of 6,300 shares of Sarepta's common stock and 6,300 restricted stock units (RSUs). The options have an exercise price of $127.90 per share, which is equivalent to the closing price of Sarepta's common stock on the day they were granted.
More on TelAve News
The options will vest over a period of four years, with one-fourth of the shares underlying each employee's option vesting on the one-year anniversary of the grant date. After that, 1/48th of the shares will vest monthly until all shares are fully vested on the fourth anniversary of the grant date. However, this is subject to each employee's continued employment with Sarepta on each vesting date.
Similarly, one-fourth of the RSUs will vest yearly on each anniversary of the grant date until they are fully vested on the fourth anniversary. Again, this is subject to each employee's continued employment with Sarepta.
This announcement highlights Sarepta's commitment to attracting and retaining top talent in their efforts towards precision genetic medicine for rare diseases. The company believes that these equity awards will serve as a strong incentive for employees to contribute towards their mission and drive success in their field.
According to Nasdaq Listing Rule 5635(c)(4), the equity awards included options to purchase a total of 6,300 shares of Sarepta's common stock and 6,300 restricted stock units (RSUs). The options have an exercise price of $127.90 per share, which is equivalent to the closing price of Sarepta's common stock on the day they were granted.
More on TelAve News
- New Website for Solo Agers Over 50
- Malcolm-Jamal Warner Returns to Columbia for an Unforgettable Evening of Poetry & Music
- Slightly Stoopid, Damian & Stephen Marley to headline Everwild Music Festival in 2025
- Parkbench13 Media Group Inc. Seeks Artists for Sync Licensing Opportunities
- The Elevated Table Project Revolutionizes Cannabis-Infused Cooking & Cocktails
The options will vest over a period of four years, with one-fourth of the shares underlying each employee's option vesting on the one-year anniversary of the grant date. After that, 1/48th of the shares will vest monthly until all shares are fully vested on the fourth anniversary of the grant date. However, this is subject to each employee's continued employment with Sarepta on each vesting date.
Similarly, one-fourth of the RSUs will vest yearly on each anniversary of the grant date until they are fully vested on the fourth anniversary. Again, this is subject to each employee's continued employment with Sarepta.
This announcement highlights Sarepta's commitment to attracting and retaining top talent in their efforts towards precision genetic medicine for rare diseases. The company believes that these equity awards will serve as a strong incentive for employees to contribute towards their mission and drive success in their field.
0 Comments
Latest on TelAve News
- Connected Technologies Delivers Cutting-Edge Technology to Landmark Properties' Student Housing Communities
- Craft Holsters Unveils Comprehensive SIG Sauer Guides for Firearm Enthusiasts
- How Technology is Making the Florida Court System More Accessible
- Alpha Platforms Revolutionizes Tower Contractor Operating Margins With Industry-First Lifts
- Discover the Culinary Heart of Le Marche: A 5-Night Food & Wine Tour + Farm to Table Cooking Classes in Italy's Hidden Gem
- The One Experience™, Inc. Announces Presenting Sponsors and Partners for Flagship Event
- Introducing HOME-OMETRY, the Social Media Network for Real Estate
- Italian iGaming Landscape Expands with Notable Merger: Gaming Report Acquires Gaming Insider
- Retrospec Appoints Nick Marvik as New Head of Growth to Lead eCommerce Expansion
- $27 Million Funding; Coverage on Sanjay Gupta/CNN for Treatment of Suicidal Depression; Nasdaq Tier Uplisting: NRx Pharmaceuticals: Stock Symbol: NRXP
- Advanced HDR by Technicolor Enables 2024 UEFA Championship's French Broadcast in High Dynamic Range
- ®Grammy Award Winner Alex Cuba releases new single "El Día Más Triste"
- Performentor, LLC Announces 2025 Unleash People Energy® Award Winners
- LAIIER Closes Oversubscribed US$4M Seed Extension Funding Round, Led by Closed Loop Partners
- Deep Learning Robotics (DLRob) Secures European Patent Office Approval for Revolutionary Robot Learning Technology
- Turbocharge Small- and Medium-Size Business Financing with Faster Funding's Innovative Business Credit Building and Financing Suite
- Inframark's Oklahoma City Team Wins OWEA Awards, Exemplary Employer Accolade
- Hitachi Construction Machinery estabelece sede regional na América Latina no Chile
- Hitachi Construction Machinery establece su sede regional para América Latina en Chile
- Hitachi Construction Machinery Establishing Latin American Regional Headquarters in Chile